Nabriva Therapeutics plc Interest Expense
Nabriva Therapeutics plc reported Interest Expense of $698.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-04-17.
Discontinued › Expense Statement
us-gaap:InterestExpense · last filed 2023-04-17
- Nabriva Therapeutics plc interest expense for the quarter ending 2021-12-31 was $223.00K, a 12.63% increase year-over-year.
- Nabriva Therapeutics plc interest expense for the quarter ending 2021-09-30 was $221.00K, a 13.67% decline year-over-year.
- Nabriva Therapeutics plc interest expense for the quarter ending 2021-06-30 was $241.00K, a 3.98% decline year-over-year.
- Nabriva Therapeutics plc interest expense for the quarter ending 2021-03-31 was $222.00K, a 78.32% decline year-over-year.
- Nabriva Therapeutics plc interest expense for fiscal 2022 was $698.00K, a 22.53% decline from fiscal 2021.
- Nabriva Therapeutics plc interest expense for fiscal 2021 was $901.00K, a 45.36% decline from fiscal 2020.
- Nabriva Therapeutics plc interest expense for fiscal 2020 was $1.65M, a 51.34% decline from fiscal 2019.
- Nabriva Therapeutics plc interest expense for fiscal 2019 was $3.39M, a 2448.12% increase from fiscal 2018.
| Period end | Interest Expense 3 month | Interest Expense 3 month as first filed | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 9 month as first filed | Interest Expense 12 month | Interest Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2022-12-31 | $698.00K 10-K · filed 2023-04-17 | ||||||
| 2021-12-31 | $223.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | $444.00K derived: sum of 2 quarters · filed 2023-04-17 | $685.00K derived: sum of 3 quarters · filed 2023-04-17 | $901.00K 10-K · filed 2023-04-17 | |||
| 2021-09-30 | $221.00K 10-Q · filed 2021-11-09 | $462.00K derived: sum of 2 quarters · filed 2021-11-09 | $678.00K 10-Q · filed 2021-11-09 | $882.00K derived: sum of 4 quarters · filed 2023-04-17 | |||
| 2021-06-30 | $241.00K 10-Q · filed 2021-08-05 | $463.00K 10-Q · filed 2021-08-05 | $661.00K derived: sum of 3 quarters · filed 2023-04-17 | $917.00K derived: sum of 4 quarters · filed 2023-04-17 | |||
| 2021-03-31 | $222.00K 10-Q · filed 2021-05-06 | $420.00K derived: sum of 2 quarters · filed 2023-04-17 | $676.00K derived: sum of 3 quarters · filed 2023-04-17 | $927.00K derived: sum of 4 quarters · filed 2023-04-17 | |||
| 2020-12-31 | $198.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | $454.00K derived: sum of 2 quarters · filed 2023-04-17 | $705.00K derived: sum of 3 quarters · filed 2023-04-17 | $1.65M 10-K · filed 2023-04-17 | $1.74M 10-K · filed 2021-03-11 | ||
| 2020-09-30 | $256.00K 10-Q · filed 2021-11-09 | $261.00K 10-Q · filed 2020-11-05 | $507.00K derived: sum of 2 quarters · filed 2021-11-09 | $1.45M 10-Q · filed 2021-11-09 | $1.54M 10-Q · filed 2020-11-05 | $2.41M derived: sum of 4 quarters · filed 2022-03-29 | |
| 2020-06-30 | $251.00K 10-Q · filed 2021-08-05 | $1.27M 10-Q · filed 2021-08-05 | $2.15M derived: sum of 3 quarters · filed 2022-03-29 | $2.86M derived: sum of 4 quarters · filed 2022-03-29 | |||
| 2020-03-31 | $1.02M 10-Q · filed 2021-05-06 | $1.90M derived: sum of 2 quarters · filed 2022-03-29 | $2.61M derived: sum of 3 quarters · filed 2022-03-29 | $3.51M derived: sum of 4 quarters · filed 2022-03-29 | |||
| 2019-12-31 | $877.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $1.59M derived: sum of 2 quarters · filed 2022-03-29 | $2.49M derived: sum of 3 quarters · filed 2022-03-29 | $3.39M 10-K · filed 2022-03-29 | $3.64M 10-K · filed 2020-03-12 | ||
| 2019-09-30 | $709.00K 10-Q · filed 2020-11-05 | $1.61M derived: sum of 2 quarters · filed 2020-11-05 | $2.51M 10-Q · filed 2020-11-05 | $2.63M derived: sum of 4 quarters · filed 2021-03-11 | |||
| 2019-06-30 | $904.00K 10-Q · filed 2020-08-06 | $1.80M 10-Q · filed 2020-08-06 | $1.92M derived: sum of 3 quarters · filed 2021-03-11 | $1.93M derived: sum of 4 quarters · filed 2021-03-11 | |||
| 2019-03-31 | $899.00K 10-Q · filed 2020-05-11 | $1.01M derived: sum of 2 quarters · filed 2021-03-11 | $1.02M derived: sum of 3 quarters · filed 2021-03-11 | $1.03M derived: sum of 4 quarters · filed 2021-03-11 | |||
| 2018-12-31 | $114.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $122.00K derived: sum of 2 quarters · filed 2021-03-11 | $129.00K derived: sum of 3 quarters · filed 2021-03-11 | $133.00K 10-K · filed 2021-03-11 | |||
| 2018-09-30 | $8.00K 10-Q · filed 2019-11-12 | $15.00K derived: sum of 2 quarters · filed 2019-11-12 | $19.00K 10-Q · filed 2019-11-12 | $16.00K derived: sum of 4 quarters · filed 2020-03-12 | |||
| 2018-06-30 | $7.00K 10-Q · filed 2019-08-08 | $11.00K 10-Q · filed 2019-08-08 | $8.00K derived: sum of 3 quarters · filed 2020-03-12 | $50.00K derived: sum of 4 quarters · filed 2020-03-12 | |||
| 2018-03-31 | $4.00K 10-Q · filed 2019-05-10 | $1.00K derived: sum of 2 quarters · filed 2020-03-12 | $43.00K derived: sum of 3 quarters · filed 2020-03-12 | $46.00K derived: sum of 4 quarters · filed 2020-03-12 | |||
| 2017-12-31 | -$3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $39.00K derived: sum of 2 quarters · filed 2020-03-12 | $42.00K derived: sum of 3 quarters · filed 2020-03-12 | $43.00K 10-K · filed 2020-03-12 | |||
| 2017-09-30 | $42.00K 10-Q · filed 2018-11-06 | $45.00K derived: sum of 2 quarters · filed 2018-11-06 | $46.00K 10-Q · filed 2018-11-06 | $86.00K derived: sum of 4 quarters · filed 2019-03-12 | |||
| 2017-06-30 | $3.00K 10-Q · filed 2018-08-09 | $4.00K 10-Q · filed 2018-08-09 | $44.00K derived: sum of 3 quarters · filed 2019-03-12 | $79.00K derived: sum of 4 quarters · filed 2019-03-12 | |||
| 2017-03-31 | $1.00K 10-Q · filed 2018-05-08 | $41.00K derived: sum of 2 quarters · filed 2019-03-12 | $76.00K derived: sum of 3 quarters · filed 2019-03-12 | ||||
| 2016-12-31 | $40.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $75.00K derived: sum of 2 quarters · filed 2019-03-12 | $75.00K 10-K · filed 2019-03-12 | ||||
| 2016-09-30 | $35.00K 10-Q · filed 2017-11-09 | $35.00K 10-Q · filed 2017-11-09 | |||||
| 2015-12-31 | $22.09M 10-K · filed 2018-03-16 | ||||||
| 2014-12-31 | $2.91M 10-K · filed 2017-03-24 |